<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01782144</url>
  </required_header>
  <id_info>
    <org_study_id>12887</org_study_id>
    <nct_id>NCT01782144</nct_id>
  </id_info>
  <brief_title>Effects of Weight Loss on Foot Structure and Function in Obese Adults: A Pilot Study</brief_title>
  <acronym>WLF</acronym>
  <official_title>Effect of Weight Loss on Foot Structure and Function in Obese Adults: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Temple University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity is a serious medical, social, and economic problem and is becoming even greater&#xD;
      concern, as the prevalence of overweight and obese individuals has steadily increased over&#xD;
      the years. Excessive body weight can have a profound influence on lower extremities,&#xD;
      including pain, degenerative disease, and compromised quality of life. However, no study&#xD;
      to-date has examined the effects of weight change on foot structure and function in&#xD;
      individuals over time. The purpose of this study is to determine the effects of weight&#xD;
      reduction on foot structure and function in obese adults. Improved understanding of the&#xD;
      relationship between body weight and foot biomechanics is needed to promote health and&#xD;
      healthier lifestyles.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Walking speed</measure>
    <time_frame>3 months</time_frame>
    <description>Change in walking speed at 3 month</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postural stability</measure>
    <time_frame>3 months</time_frame>
    <description>Change in Fall Risk Test Score as measured by the BioDex Balance System.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peak plantar pressure</measure>
    <time_frame>3 months</time_frame>
    <description>Change in dynamic peak plantar pressure during barefoot walking.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Instruments of pain and disability</measure>
    <time_frame>3 months</time_frame>
    <description>Change in answers on the following questionnaires: Revised Foot Function Index, the Medical Outcomes Study Short Form 36 (SF-36), Western Ontario and McMaster Universities Osteoarthritis Index.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arch Height Drop</measure>
    <time_frame>3 months</time_frame>
    <description>Change in arch height in standing compared to sitting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activities of Daily Living</measure>
    <time_frame>3 months</time_frame>
    <description>Change in 50' walk time and pain, stair ascend/descend time and pain, and sit-to-stand.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>NutriSystem</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>weekly behavior group weight loss education</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Education</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>monthly behavior group weight loss education</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NutriSystem portion-controlled pre-packaged meals</intervention_name>
    <arm_group_label>Education</arm_group_label>
    <arm_group_label>NutriSystem</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women between the ages of 50 to 75, inclusive&#xD;
&#xD;
          -  Body Mass Index is â‰¥ 30 kg/m2 but &lt; 45 kg/m2 and body weight &lt; 300 pounds&#xD;
&#xD;
          -  Able to ambulate safely without the use of a walking aid (cane, crutches, or walker)&#xD;
&#xD;
          -  Able to understand the information in the informed consent form and is willing and&#xD;
             able to comply with the study-related procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetes, stroke, end stage kidney disease requiring hemodialysis, or widespread&#xD;
             malignant disease, gallbladder disease&#xD;
&#xD;
          -  Severe peripheral vascular disease (defined as 1 &lt; palpable pedal pulse and&#xD;
             claudication pain in less than two blocks)&#xD;
&#xD;
          -  Pregnant or nursing, as weight and hormonal changes during pregnancy may affect foot&#xD;
             structure and function, which could confound the results of the study. Therefore,&#xD;
             women who are pregnant or nursing will be excluded from the study.&#xD;
&#xD;
          -  Not willing or able to make the required quarterly follow-up visits&#xD;
&#xD;
          -  Insufficient (corrected) vision to complete the questionnaires&#xD;
&#xD;
          -  Food allergies to the Nutrisystem, Inc. meal plan used in this protocol&#xD;
&#xD;
          -  Participation in another formal weight loss program within last 6 months&#xD;
&#xD;
          -  Uncontrolled hypertension (systolic blood pressure &gt; 180 or diastolic blood pressure &gt;&#xD;
             100 mmHg). Participants on medication treating hypertension for at least three months&#xD;
             are allowable.&#xD;
&#xD;
          -  Known atherosclerotic cardiovascular disease&#xD;
&#xD;
          -  History of congestive heart failure&#xD;
&#xD;
          -  History of a non-skin malignancy within the previous 5 years&#xD;
&#xD;
          -  Any major active rheumatologic, pulmonary, hepatic, renal, dermatologic disease or&#xD;
             inflammatory condition&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jinsup Song, DPM, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Temple University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gait Study Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>January 30, 2013</study_first_submitted>
  <study_first_submitted_qc>January 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2013</study_first_posted>
  <last_update_submitted>October 13, 2020</last_update_submitted>
  <last_update_submitted_qc>October 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Foot pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

